ESC 365 - Balancing bleeding risk and effectiveness in patients requiring oral anticoagulation - State of the art

ESC Premium Access

Balancing bleeding risk and effectiveness in patients requiring oral anticoagulation - State of the art

Session: Bleeding risk and oral anticoagulation

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor P. Kirchhof (Hamburg, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

66 presentations

15 followers

3 more presentations in this session

Novel thromboelastography point-of-care test detects all commercially available DOACs at therapeutic concentrations and classifies them as direct thrombin or factor Xa inhibitors with high consistency

Speaker: Doctor H. Achneck (Braintree, US)

Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score

Speaker: Doctor M. Proietti (Milan, IT)

How to best predict bleeding risk: clinical or biological tests?

Speaker: Professor R. Kiss (Budapest, HU)

Access the full session

Bleeding risk and oral anticoagulation

Speakers: Professor P. Kirchhof, Doctor H. Achneck, Doctor M. Proietti, Professor R. Kiss

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources